Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Total Current Liabilities (2016 - 2025)

Perspective Therapeutics' Total Current Liabilities history spans 15 years, with the latest figure at $20.6 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 26.74% year-over-year to $20.6 million; the TTM value through Sep 2025 reached $20.6 million, down 26.74%, while the annual FY2024 figure was $18.2 million, 16.38% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $20.6 million at Perspective Therapeutics, up from $13.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $28.1 million in Q3 2024 and bottomed at $1.8 million in Q3 2021.
  • The 5-year median for Total Current Liabilities is $8.1 million (2023), against an average of $9.3 million.
  • The largest annual shift saw Total Current Liabilities skyrocketed 402.37% in 2023 before it dropped 26.74% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $1.8 million in 2021, then skyrocketed by 69.0% to $3.1 million in 2022, then surged by 402.37% to $15.7 million in 2023, then grew by 16.38% to $18.2 million in 2024, then grew by 13.1% to $20.6 million in 2025.
  • Per Business Quant, the three most recent readings for CATX's Total Current Liabilities are $20.6 million (Q3 2025), $13.0 million (Q2 2025), and $12.7 million (Q1 2025).